December 6, 2025
West Contra Costa Unified educators strike, demanding fair pay and support
Educators in the West Contra Costa Unified School District went on strike on Thursday, demanding higher wages, support for international teachers on H-1B visas and teacher retention, among other issues. The district employs 1,400 educators, all of whom are on strike after 10 months of negotiations, across dozens of schools. This marks the first teachers strike of the school...December 6, 2025
US Energy Department offers $134M to boost rare earth recovery projects
The agency plans to fund efforts to draw rare earth metals from discarded electronics and other sources to strengthen the domestic critical mineral supply chain. Continue reading →December 6, 2025
Old Navy taps DoorDash for same-day deliveries
The retailer joins a growing roster of companies who have tapped into the app’s on-demand retail delivery services in recent years. Continue reading →December 6, 2025
Nexperia spat shows automotive supply chains vulnerable to geopolitics
Manufacturers must guard against production disruptions from other international dustups, says Moody’s Supply Chain Director Sapna Amlani. Continue reading →December 6, 2025
Threat Landscape Grows Increasingly Dangerous for Manufacturers
Manufacturers are the top target for cyberattacks in 2025 because of their still-plentiful cybersecurity gaps and a lack of expertise. Continue reading →December 6, 2025
India Rolls Back App Mandate Amid Surveillance Concerns
Remember when Apple put that U2 album in everyone’s music libraries? India wanted to do that to all of its citizens, but with a cybersecurity app. It wasn’t a good idea. Continue reading →December 6, 2025
GISEC GLOBAL 2026 – The Middle East & Africa’s Largest Cybersecurity Event
Continue reading →December 6, 2025
Samsung Bioepis announces launch of two new denosumab biosimilars in Europe
Samsung Bioepis has announced the European launch of Obodence and Xbryk, two new denosumab biosimilars approved for the treatment of bone disease. Obodence, referencing Amgen’s Prolia, has been approved for the treatment of osteoporosis in postmenopausal women and in men at increased risk of fractures, as well as for bone loss associated with prostate cancer The post...December 6, 2025
Vetter announces leadership transition as Thomas Otto retires
Vetter has announced the retirement of managing director Thomas Otto amid strategic plans for restructuring its management team. Otto has served at Vetter for over 35 years and has been heavily involved in shaping the company’s sustainable development and continued growth. He will step down at the end of 2025 and take on an advisory The post Vetter announces leadership...December 6, 2025
Teva announces positive results from trial of AJOVY for migraine
Teva has announced positive results from the phase 4 PEARL study of AJOVY (fremanezumab), its treatment for chronic (CM) and episodic migraine (EM). AJOVY is an anti-calcitonin gene-related peptide (CGRP) monoclonal antibody administered as a subcutaneous injection. The PEARL study of AJOVY took place over 24 months, aiming to assess the impact of fremanezumab on The post...December 6, 2025
US, allies urge critical infrastructure operators to carefully plan and oversee AI use
New guidance attempts to temper companies’ enthusiasm for the latest exciting technology. Continue reading →December 6, 2025














